Live Breaking News & Updates on Thrombus

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Researchers provided an overview of nanomedicine strategies to treat coronavirus disease 2019 (COVID-19)-induced thrombosis.

Drug-administration , Nature-nanotechnology , Industry-focus , Coronavirus-disease-covid-19 , Anoparticles , Ars , Ars-cov-2 , Hrombosis , Ce2 , Lood , Ell

The Plaque Hypothesis: Focus on Vulnerable Lesions to Cut Events

A new strategy is needed targeting unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major adverse cardiac events, a new review suggests.

Boston , Massachusetts , United-states , Boston-university , Peter-libby , Williame-boden , Boston-university-school-of-medicine , Boston-university-school , Medscape-cardiology , Ischemia-hypothesis , Cv

Tiny, Menacing Microclots May Explain Long COVID's Symptoms

Some long COVID researchers have suspected smaller, less obvious blood clots may be causing many of the puzzling symptoms reported by patients who have lasting effects of the virus.

Germany , New-york , United-states , South-africa , United-kingdom , Stellenbosch , Western-cape , Massachusetts , Douglas-kell , Lumbrokinase-serrapeptase , Etheresia-resia-pretorius , Michael-vanelzakker

Highly Selective Bailout GPI May Benefit in STEMI-PCI Subgroup

Bailout GP IIb/IIIa inhibition ups bleeding risk without preventing ischemic events in STEMI-PCI patients also having thrombectomy, a registry study suggests. One subgroup may have had a net benefit.

China , United-states , Tianjin , Chinese , American , American-heart-association , Academic-research-consortium , National-natural-science-foundation-of-china , Pfizer , Astrazeneca , Chinese-society-of-cardiology

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

Thrombosis-research , Coronavirus-disease-covid-19 , Ovid-19 , Thromboembolism , Venous-thromboembolism , Leeding , Ancer , Oronavirus , Iabetes , Fficacy , Neoplasm

New Biomarker Flags VTE Risk in COVID-19 Patients

New findings point to a biomarker even more sensitive than D-dimer in detecting risk for VTE in hospitalized patients with COVID-19.

United-states , Ann-arbor , Michigan , Berlin , Germany , American , Salim-hayek , Geoffrey-barnes , Walden-biosciences , Jochen-reiser , University-of-michigan-frankel-cardiovascular-center-clinics , National-institute-of-diabetes

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

Aimee-molineux , Neha-mathur , Neha-mathuraug , Elevated-myl , Blood , Oronavirus-disease-covid-19 , Ovid-19 , Blood-vessels , Ell , Oronavirus , D-dimer